Fairley JA - Search Results

1

International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA.

Keppens C, Dequeker EMC, Patton SJ, Normanno N, Fenizia F, Butler R, Cheetham M, Fairley JA, Williams H, Hall JA, Schuuring E, Deans ZC; IQN Path ASBL. Keppens C, et al. Among authors: fairley ja. BMC Cancer. 2018 Aug 9;18(1):804. doi: 10.1186/s12885-018-4694-x. BMC Cancer. 2018. PMID: 30092778 Free PMC article.

2

RAS screening in colorectal cancer: a comprehensive analysis of the results from the UK NEQAS colorectal cancer external quality assurance schemes (2009-2016).

Richman SD, Fairley J, Butler R, Deans ZC. Richman SD, et al. Virchows Arch. 2017 Dec;471(6):721-729. doi: 10.1007/s00428-017-2162-7. Epub 2017 Jun 26. Virchows Arch. 2017. PMID: 28653203 Free PMC article.

3

External quality assessment of BRAF molecular analysis in melanoma.

Deans ZC, Wallace A, O'Sullivan B, Purvis A, Camus S, Fairley JA, Gonzalez D. Deans ZC, et al. Among authors: fairley ja. J Clin Pathol. 2014 Feb;67(2):120-4. doi: 10.1136/jclinpath-2013-201848. Epub 2013 Oct 4. J Clin Pathol. 2014. PMID: 24098023

4

IQN path ASBL report from the first European cfDNA consensus meeting: expert opinion on the minimal requirements for clinical ctDNA testing.

Deans ZC, Butler R, Cheetham M, Dequeker EMC, Fairley JA, Fenizia F, Hall JA, Keppens C, Normanno N, Schuuring E, Patton SJ. Deans ZC, et al. Among authors: fairley ja. Virchows Arch. 2019 Jun;474(6):681-689. doi: 10.1007/s00428-019-02571-3. Epub 2019 Apr 26. Virchows Arch. 2019. PMID: 31028539 Free PMC article.

5

Results of a worldwide external quality assessment of cfDNA testing in lung Cancer.

Fairley JA, Cheetham MH, Patton SJ, Rouleau E, Denis M, Dequeker EMC, Schuuring E, van Casteren K, Fenizia F, Normanno N, Deans ZC. Fairley JA, et al. BMC Cancer. 2022 Jul 12;22(1):759. doi: 10.1186/s12885-022-09849-x. BMC Cancer. 2022. PMID: 35820813 Free PMC article.

6

How close are we to standardised extended RAS gene mutation testing? The UK NEQAS evaluation.

Richman SD, Fairley J, Butler R, Deans ZC. Richman SD, et al. J Clin Pathol. 2017 Jan;70(1):58-62. doi: 10.1136/jclinpath-2016-203822. Epub 2016 Sep 28. J Clin Pathol. 2017. PMID: 27681846 Free PMC article.

7

Results of the UK NEQAS for Molecular Genetics reference sample analysis.

Richman SD, Fairley J, Hall JA, Nataraj N, Bhide M, Lau A, Norman KL, Deans ZC. Richman SD, et al. Among authors: fairley j. J Clin Pathol. 2018 Nov;71(11):989-994. doi: 10.1136/jclinpath-2018-205277. Epub 2018 Jul 20. J Clin Pathol. 2018. PMID: 30030291 Free PMC article.

8

HGVS Nomenclature in Practice: An Example from the United Kingdom National External Quality Assessment Scheme.

Deans ZC, Fairley JA, den Dunnen JT, Clark C. Deans ZC, et al. Among authors: fairley ja. Hum Mutat. 2016 Jun;37(6):576-8. doi: 10.1002/humu.22978. Epub 2016 Mar 18. Hum Mutat. 2016. PMID: 26919400

9

Tumor mutation burden testing: a survey of the International Quality Network for Pathology (IQN Path).

Fenizia F, Wolstenholme N, Fairley JA, Rouleau E, Cheetham MH, Horan MP, Torlakovic E, Besse B, Al Dieri R, Tiniakos DG, Deans ZC, Patton SJ, Normanno N. Fenizia F, et al. Among authors: fairley ja. Virchows Arch. 2021 Dec;479(6):1067-1072. doi: 10.1007/s00428-021-03093-7. Epub 2021 Apr 15. Virchows Arch. 2021. PMID: 33856555 Free PMC article.

10

Making the most of pathological specimens: molecular diagnosis in formalin-fixed, paraffin embedded tissue.

Fairley JA, Gilmour K, Walsh K. Fairley JA, et al. Curr Drug Targets. 2012 Nov;13(12):1475-87. doi: 10.2174/138945012803530125. Curr Drug Targets. 2012. PMID: 22974391 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

154 results

Search Page